Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CorMedix Inc.CRMD · Entity 5280 | Director | May 15, 2017 | May 17, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CorMedix Inc.
Report date May 15, 2017 · Filed May 17, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,000 |
Reported balance
After 2017-05-15 transaction · row 1
1 source rowRow 1 · 2017-05-15 · Purchase · Acquired 10,000 · Balance 10,000 |
| Phantom StockSEC Table II · derivative / convertible security | Direct | 15,306 |
Reported balance
After 2017-05-15 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2017-05-15 · Grant · Acquired 15,306 · Balance 15,306 F3: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. |
| Phantom StockSEC Table II · derivative / convertible security | Direct | 3,472 |
Reported balance
Holding disclosure · report date 2017-05-15 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 3,472 F3: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. |
| Phantom StockSEC Table II · derivative / convertible security | Direct | 4,143 |
Reported balance
Holding disclosure · report date 2017-05-15 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 4,143 F3: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. |
| Phantom StockSEC Table II · derivative / convertible security | Direct | 1,847 |
Reported balance
Holding disclosure · report date 2017-05-15 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 1,847 F3: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. |
| Phantom StockSEC Table II · derivative / convertible security | Direct | 1,176 |
Reported balance
Holding disclosure · report date 2017-05-15 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 1,176 F3: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. |
| Phantom StockSEC Table II · derivative / convertible security | Direct | 2,459 |
Reported balance
Holding disclosure · report date 2017-05-15 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 2,459 F3: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. |
| Phantom StockSEC Table II · derivative / convertible security | Direct | 3,125 |
Reported balance
Holding disclosure · report date 2017-05-15 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 3,125 F3: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. |
| Phantom StockSEC Table II · derivative / convertible security | Direct | 3,968 |
Reported balance
Holding disclosure · report date 2017-05-15 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 3,968 F3: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. |
| Phantom StockSEC Table II · derivative / convertible security | Direct | 2,767 |
Reported balance
Holding disclosure · report date 2017-05-15 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 2,767 F3: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. |
| Phantom StockSEC Table II · derivative / convertible security | Direct | 4,335 |
Reported balance
Holding disclosure · report date 2017-05-15 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 4,335 F3: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. |
| Stock Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $2.24 · Expires 2027-02-21 | Direct | 40,000 |
Reported balance
Holding disclosure · report date 2017-05-15 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 40,000 F1: These options vest in full on the first anniversary of the date of grant, subject to continued service on the board. |
| Stock Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $2.11 · Expires 2024-04-05 | Direct | 15,000 |
Reported balance
Holding disclosure · report date 2017-05-15 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 15,000 F4: 5,000 shares vest upon completion of the April 2014 milestone, 10,000 shares vest upon completion of another milestone by the third quarter of 2014. |
| Stock Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $2.79 · Expires 2024-02-27 | Direct | 30,000 |
Reported balance
Holding disclosure · report date 2017-05-15 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 30,000 F1: These options vest in full on the first anniversary of the date of grant, subject to continued service on the board. |
| Stock Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $5.62 · Expires 2025-03-01 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2017-05-15 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 50,000 F1: These options vest in full on the first anniversary of the date of grant, subject to continued service on the board. |
| Stock Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $1.91 · Expires 2026-02-21 | Direct | 90,000 |
Reported balance
Holding disclosure · report date 2017-05-15 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 90,000 F1: These options vest in full on the first anniversary of the date of grant, subject to continued service on the board. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 12,232 |
Reported balance
Holding disclosure · report date 2017-05-15 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 12,232 F2: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. |
Filing footnotes · ownership attribution and instrument terms
F1: These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
F2: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
F3: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
F4: 5,000 shares vest upon completion of the April 2014 milestone, 10,000 shares vest upon completion of another milestone by the third quarter of 2014.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2017 Filed May 17, 2017 20:07 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantPhantom Stock · Derivative | 15,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001354488-17-000514 · issuerdirect_section16.xml · derivative · entry 17 GEORGE MICHAEL W · CIK 0001190102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,306 Underlying: Common Stock · 15,306 shares Expires not disclosed F3 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F3 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F3 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| May 15, 2017 Filed May 17, 2017 20:07 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 10,000 | $0.50 | $4,990.00 |
DisclosureSEC source: 0001354488-17-000514 · issuerdirect_section16.xml · nonDerivative · entry 1 GEORGE MICHAEL W · CIK 0001190102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:06 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units · Derivative | 12,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001354488-17-000309 · issuerdirect_section16.xml · derivative · entry 2 GEORGE MICHAEL W · CIK 0001190102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,232 Underlying: Common Stock · 12,232 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:06 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 40,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001354488-17-000309 · issuerdirect_section16.xml · derivative · entry 1 GEORGE MICHAEL W · CIK 0001190102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2027-02-21 F1 · derivative.exercise_date: These options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:02 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchasePhantom Stock · Derivative | 3,472 | $7,500.00 Strike: $0.00 | $26,040,000.00 |
DisclosureSEC source: 0001354488-17-000268 · issuerdirect_section16.xml · derivative · entry 1 GEORGE MICHAEL W · CIK 0001190102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,472 Underlying: Common Stock · 3,472 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F2 · shares: These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation of directors' fees. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 21:07 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchasePhantom Stock · Derivative | 4,143 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001354488-16-008520 · issuerdirect_section16.xml · derivative · entry 1 GEORGE MICHAEL W · CIK 0001190102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,143 Underlying: Common Stock · 4,143 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F2 · shares: These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation of directors' fees. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.